← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2009Last known activity
Apr 1, 2025
Timeline
1880s
- Jun 1, 1881
First People's Hospital of Foshan— Founded
Drugs by trial phase (54 distinct, 41 trials)
Phase 4 (14 own, 0 via acquisition)
Phase 3 (21 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Behavior, Addictive
- Carcinoma
- Cardiomyopathies
- Cognitive Dysfunction
- Colorectal Neoplasms
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis, Chronic
- Infarction
- Ischemia
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Lung Neoplasms
- Mucositis
- Myocardial Infarction
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Opioid-Related Disorders
- Peritoneal Neoplasms
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Small Cell Lung Carcinoma
- ST Elevation Myocardial Infarction
- Stomatitis
Recent trials (45)
- NCT06904183CollaboratorPhase 2Apr 1, 2025
- NCT06763666CollaboratorPhase 4Feb 28, 2025
- NCT06462105CollaboratorN/AJul 5, 2024
- NCT06333821OfficialPhase 3Apr 1, 2024
- NCT06041477CollaboratorPhase 3Sep 30, 2023
- NCT05985798CollaboratorPhase 3Aug 1, 2023
- NCT05467852CollaboratorPhase 3Dec 10, 2022
- NCT05622474CollaboratorN/ANov 30, 2022
- NCT05524168CollaboratorPhase 2Nov 30, 2022
- NCT05476432CollaboratorPhase 3Jul 26, 2022
- NCT05342792CollaboratorPhase 3Apr 17, 2022
- NCT05196945CollaboratorPhase 4Mar 31, 2022
- NCT05263219CollaboratorPhase 3Feb 10, 2022
- NCT05182463Overall official - principal investigatorPhase 4Jan 8, 2022
- NCT05182463OfficialPhase 4Jan 8, 2022
Details
- Founded
- Foshan, CN Jun 1, 1881
- Last known activity
- Apr 1, 2025